Alambic Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-42,600
Closed -$1.95M 699
2017
Q1
$1.95M Buy
42,600
+32,000
+302% +$1.59M 0.24% 141
2016
Q4
$558K Sell
10,600
-3,550
-25% -$172K 0.1% 307
2016
Q3
$631K Sell
14,150
-3,750
-21% -$163K 0.15% 236
2016
Q2
$683K Buy
+17,900
New +$786K 0.17% 216
2016
Q1
Sell
-14,150
Closed -$686K 534
2015
Q4
$686K Buy
+14,150
New +$629K 0.41% 75

Other funds holding SYNH

Alambic Investment Management's SYNH Position: Q2 2017 in Review

Alambic Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 42,600 shares — an estimated $1.95M sold.

Alambic Investment Management first reported a position in SYNH in Q4 2015 and held it in 5 quarters. The position peaked at $1.95M in Q1 2017. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Alambic Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Alambic Investment Management sold 42,600 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $1.95M.
  • Alambic Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 5 quarters.
  • Alambic Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.95M in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Alambic Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.